Literature DB >> 15876930

Potential strategies to reduce the burden of pertussis.

Kevin Forsyth1, Tina Tan, Carl-Heinz Wirsing von König, J Jaime Caro, Stanley Plotkin.   

Abstract

Pertussis continues to be a significant cause of morbidity and mortality among nonimmunized young infants. Although the inception of childhood pertussis immunization programs has significantly reduced the occurrence of the disease in children, waning vaccine-induced immunity permits the disease to affect adolescents and adults, who in turn transmit the disease to unimmunized or incompletely immunized infants. The Global Pertussis Initiative brought together experts from 17 countries around the world to evaluate strategies to improve disease control. Seven strategies were considered: (1) universal adult immunization; (2) selective immunization of mothers and close family contacts of newborns; (3) selective immunization of health care workers; (4) selective immunization of child care workers; (5) universal immunization of adolescents; (6) preschool booster at 4-6 years of age; and (7) reinforcement and/or improvement of current infant and toddler immunization strategies. Because immunization programs vary widely from country to country, no single strategy is likely to be appropriate for all. Moreover it would be helpful to have additional data to support the strategies and provide a better understanding of the disease so that new approaches can be monitored effectively. However, certain steps can be taken now to reduce the incidence of pertussis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15876930     DOI: 10.1097/01.inf.0000160917.29723.03

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  14 in total

1.  Maternal immunity provides protection against pertussis in newborn piglets.

Authors:  Shokrollah Elahi; Rachelle M Buchanan; Lorne A Babiuk; Volker Gerdts
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine.

Authors:  Natasha B Halasa; Alice O'Shea; Jian R Shi; Bonnie J LaFleur; Kathryn M Edwards
Journal:  J Pediatr       Date:  2008-04-28       Impact factor: 4.406

3.  The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study.

Authors:  Qi Zhang; Huizhen Zheng; Meizhen Liu; Ke Han; Jun Shu; Chenggang Wu; Ning Xu; Qiushui He; Huiming Luo
Journal:  BMC Infect Dis       Date:  2012-06-20       Impact factor: 3.090

4.  Vaccination information fathers receive during pregnancy and determinants of infant vaccination timeliness.

Authors:  Catherine A Gilchrist; Carol Chelimo; Ryan Tatnell; Polly Atatoa Carr; Carlos A Camargo; Susan Morton; Cameron C Grant
Journal:  Hum Vaccin Immunother       Date:  2021-11-19       Impact factor: 3.452

Review 5.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

Review 6.  Symptomatic treatment of the cough in whooping cough.

Authors:  Kay Wang; Silvana Bettiol; Matthew J Thompson; Nia W Roberts; Rafael Perera; Carl J Heneghan; Anthony Harnden
Journal:  Cochrane Database Syst Rev       Date:  2014-09-22

7.  Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice.

Authors:  Nathalie Mielcarek; Anne-Sophie Debrie; Severine Mahieux; Camille Locht
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

8.  Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis.

Authors:  Sabine C de Greeff; Hester E de Melker; Pieter G M van Gageldonk; Joop F P Schellekens; Fiona R M van der Klis; Liesbeth Mollema; Frits R Mooi; Guy A M Berbers
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

9.  Bordetella pertussis, Finland and France.

Authors:  Valérie Caro; Annika Elomaa; Delphine Brun; Jussi Mertsola; Qiushui He; Nicole Guiso
Journal:  Emerg Infect Dis       Date:  2006-06       Impact factor: 6.883

10.  Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003.

Authors:  Shane Byrne; Andrew T Slack
Journal:  BMC Infect Dis       Date:  2006-03-16       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.